Indian pharmaceutical companies Sun Pharma, Lupin, and Dr Reddy's Laboratories are conducting recalls in the US due to ...

Domestic drug majors Sun Pharma, Lupin and Dr Reddy's Laboratories are recalling drugs in the US market due to manufacturing ...

Sun Pharma, Lupin and Dr Reddy's Laboratories are recalling various drugs in the US due to manufacturing issues and product mix-ups, as reported by the US health regulator.

New Delhi, Domestic drug majors Sun Pharma, Lupin and Dr Reddy's Laboratories are recalling drugs in the US market due to manufacturing issues and product mix up, according to the US health regulator.

The Carbamazepine extended-release tablets are indicated for use as an anti-convulsant drug and also for the treatment of the ...

A warning letter is a serious communication from the USFDA that signifies a potential risk to public health or safety due to ...

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration ...

Lupin receives USFDA approval for generic Liraglutide Injection and Glucagon, expanding access to diabetes treatments.

Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to ...

The company is going to announce results for the quarter ended June 30th, 2025 on July 23, 2025 after the board meeting.

Zydus Lifesciences Ltd on Thursday said it has received tentative approval from the US health regulatory agency for its generic version of cancer treatment drug Ibrutinib tablets.

Zydus Lifesciences receives tentative USFDA approval for its generic Ibrutinib tablets, used to treat various blood cancers.